Scalable rubella production in scale-X™ bioreactor with MRC-5 cells

Published on: 

Sponsored Content

This application note demonstrates the successful transfer, optimization and scale-up of the Rubella vaccine manufacturing process from static flasks to scale-X™ bioreactors.